GSK receives record fine in China for bribing doctors
Pharmaceutical firm GlaxoSmithKline have been fined $490m (£297m) after being found guilt of bribery by a Chinese court.
The firm was convicted of bribing doctors and hospitals in China in order to get their products promoted.
GSK's former head of Chinese operations, Mark Reilly, received a three-year prison sentence, which is suspended, and is set to be deported.
Theo Leggett reports.
19 Sep 2014
- From the section Business